Top Markets
#1 MowCat MowCat +631.35%
#2 龙虾 (Lobster) 龙虾 (Lobster) +79.42%
#3 Magma Finance Magma Finance +40.29%
#4 DeXe DeXe +35.60%
#5 Akedo Akedo +28.32%
#6 Cortex Cortex +23.99%
#7 SIXSEVEN SIXSEVEN +22.24%
#8 MarsCoin MarsCoin +18.02%
#9 OpenEden OpenEden +16.05%
#10 Pons Pons +15.08%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Classement en actions #8210
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Prix de l'action
$24.80
Capitalisation boursière
$1.33B
Changement (1 jour)
-5.54%
Changement (1 an)
-
Pays
US
Échange Seaport Therapeutics, Inc. Common Stock (SPTX)

Catégorie

Healthcare
Revenus pour Seaport Therapeutics, Inc. Common Stock (SPTX)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Seaport Therapeutics, Inc. Common Stock, le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Seaport Therapeutics, Inc. Common Stock de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH